Lexeo Therapeutics (LXEO) Net Preferred Shares Issued and Repurchased (2022)
Lexeo Therapeutics' Net Preferred Shares Issued and Repurchased was -$1,000 in Q4 2022.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Net Preferred Shares Issued and Repurchased (2022) Analysis & Trends
For FY2022, Net Preferred Shares Issued and Repurchased at Lexeo Therapeutics came in at $20,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Pref. Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lexeo Therapeutics | 277.54 Mn | 277.54 Mn | - | - |
API Access
Lexeo Therapeutics Net Preferred Shares Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-preferred-shares-issued-and-repurchased", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();